Other headlines: Cardiac cath usage declinesViztek launches mammo PACS viewer
An ultrasound scanner so small it fits in the palm of your hand will soon enter the U.S. market from industry newcomer Signostics. The Australian firm has gotten the go-ahead from the FDA to market the "personal ultrasound" scanner, which the company plans to package as a cost-effective device for individual health professionals to use in their clinical practices. The scanner weighs about half a pound and will be priced at a fraction of the cost of cart-based systems, according to the firm. Primary targets are emergency medicine, primary care, remote healthcare, critical care, pediatrics, musculoskeletal, palliative care, and sports medicine. Signostics will tout applications including assessment of trauma patients and abdominal aortic aneurysm screening, as well as basic obstetric exams, such as pregnancy viability and fetal positioning. Physician-engineer Dr. Neil Bartlett founded Signostics in Adelaide, Australia, in January 2005, later establishing a U.S. office in Palo Alto, CA. The company has raised about $8 million from angel investors, Australian government grant providers, and Playford Capital. Another $4 million is expected to close shortly.
The number of cases handled in cath labs is going down, according to a recent survey performed by IMV, a market research firm in Des Plaines, IL. These labs had shown steady growth, but the pattern changed direction abruptly in 2007, falling about 10% that year and another 1% the next. IMV linked the decline to the advent of CT coronary angiography, but noted that other factors may be involved. These include a controversy over the use of drug-eluting stents that developed around 2005-2006, which may have reduced the number of therapeutic coronary cases, and increased use of pre-authorization policies by third-party insurers.
A new full-featured mammography viewer from Viztek will be marketed to work with the company's Opal-RAD PACS, as well as any other PACS supporting DICOM query/retrieve for mammography. The viewer, which is configurable for simultaneous gray scale and color, can display breast images from full-field digital mammography systems, computed radiography, and MR. Major computer-aided detection systems can be launched from the viewer toolbar.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.